Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy.

about

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy.

Item

http://www.wikidata.org/entity/Q35762221

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy.

@ast

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy.

@en

type

Item

label

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy.

@ast

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy.

@en

prefLabel

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy.

@ast

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy.

@en

P1476

Evaluation of N-acetylcysteine for the prevention of contrast-induced nephropathy.

@en

P2093

Andrew J Crannage

http://www.w3.org/2001/XMLSchema#string

Sara K Richter

http://www.w3.org/2001/XMLSchema#string

P2860

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

Clinical practice. Preventing nephropathy induced by contrast medium

Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis

Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.

Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

Nephrotoxicity of contrast media and protective effects of acetylcysteine.

P304

27297

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3402/JCHIMP.V5.27297

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

278298217

http://www.w3.org/2001/XMLSchema#string

P698

26091655

http://www.w3.org/2001/XMLSchema#string

P932

4475268

http://www.w3.org/2001/XMLSchema#string